Literature DB >> 3737057

Surgical treatment of women found to have invasive cervix cancer at the time of total hysterectomy.

J W Orr, G C Ball, S J Soong, K D Hatch, E E Partridge, J M Austin.   

Abstract

Twenty-three patients were referred after the unexpected finding of invasive cervix cancer at the time of total hysterectomy. Each was deemed a candidate for additional therapy and was treated surgically with a radical reoperation consisting of a lymphadenectomy, radical parametrectomy, and upper vaginectomy. When compared with patients undergoing radical hysterectomy at this institution, this reoperation was not technically more difficult as judged by the objective measures of operative time and blood loss. The risk of perioperative morbidity was not greater than radical hysterectomy. The surgical findings obviated the need for additional radiation therapy in more than 73% of patients. While therapy for all patients must be individualized, a radical reoperation should be considered a safe and efficacious alternative to pelvic radiation for patients who are deemed to require additional therapy in this clinical situation.

Entities:  

Mesh:

Year:  1986        PMID: 3737057     DOI: 10.1097/00006250-198609000-00012

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Early cervical cancer.

Authors:  K H Lu; T W Burke
Journal:  Curr Treat Options Oncol       Date:  2000-06

2.  Robotic-assisted radical parametrectomy in patients with malignant gynecological tumors.

Authors:  Grigor A Gorchev; Slavcho T Tomov; Zdravka V Radionova; Lachezar S Tanchev
Journal:  J Robot Surg       Date:  2012-12-04

3.  A comparison of laparoscopic and abdominal radical parametrectomy for cervical or vaginal apex carcinoma and stage II endometrial cancer after hysterectomy.

Authors:  Hongyuan Jiang; Lianxi Qu; Xishi Liu; Keqin Hua; Huan Xu; Sun-Wei Guo
Journal:  JSLS       Date:  2013 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.